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Abstract
Background: Toxoplasmosis is a ubiquitous zoonotic disease caused by Toxoplasma gondii. Blood and blood products can be a prob-
able route of T. gondii transmission, especially in patients undergoing multiple transfusions.
Objectives: The aim of this cross-sectional study was to determine the prevalence of T. gondii infection among healthy blood donors
in Chaharmahal and Bakhtiari province.
Methods: We collected 385 blood samples from blood donors referring to the three biggest Blood Transfusion Organization Centers
in the province during the period from January to June 2017. IgG and IgM antibodies against T. gondii were examined using enzyme-
linked immunosorbent assay. Moreover, all samples were tested by loop-mediated isothermal amplification (LAMP) method for the
detection of DNA of T. gondii.
Results: The seroprevalence rates of IgG and IgM anti-T. gondii antibodies were 37.9% and 1.56%, respectively. With the LAMP method,
1.56% of the samples were positive for the DNA of T. gondii. Of these, four (1.04%) were seropositive for both IgG and IgM and two
(0.52%) were positive only for IgG. Moreover, statistical analyses indicated that several risk factors including gender, age, contact
with cats, and consumption of undercooked meat were significantly related to T. gondii seropositivity in blood donors.
Conclusions: This study indicated that anti-T. gondii antibodies were highly prevalent among apparently healthy blood donors in
Southwest Iran. There was a possibility of infection transmission by blood transfusion while there is a lack of screening tests for
Toxoplasma infection in the Blood Transfusion Organizations. It is strongly suggested that appropriate and sensitive screening
programs be designed by the LAMP method for the detection of T. gondii in blood donors.
Keywords: Blood Donors, Toxoplasmosis, Seroprevalence, Loop-Mediated Isothermal Amplification, Chaharmahal and Bakhtiari
Province
1. Background
Toxoplasmosis is one of the widespread serious
zoonotic parasitic diseases in humans and animals
worldwide caused by a single-cell obligate intracellular
opportunistic protozoan belonging to the phylum Api-
complexa (1). Human toxoplasmosis occurs postnatally
(horizontally) through consuming or handling viable
tissue cysts of undercooked or raw meat, consuming con-
taminated food (unwashed raw fruits and vegetables), and
drinking water contaminated with sporulated oocysts or
unpasteurized milk containing viable tachyzoites. More-
over, tachyzoites in the blood may be crossed to the fetus
via the placenta when an uninfected woman acquires the
infection during pregnancy (2, 3). Another way of infection
transmission is through organ transplantation or blood
transfusion from infected donors to susceptible recipients
(Toxoplasma-seronegative patients) (4-8).
Epidemiological surveys demonstrate that toxoplas-
mosis has a global distribution with a highly variable
prevalence from 1% to 90% in various areas of different
countries. It is estimated that approximately 25% to 30%
of the world’s population is chronically infected with Tox-
oplasma gondii, especially in developing countries (4, 9).
Human toxoplasmosis in healthy adults with normal im-
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mune systems is usually an asymptomatic chronic dis-
ease without clinical symptoms or with self-limited symp-
toms. However, in the fetus and newborns who are con-
genitally infected, it can cause congenital anomalies such
as stillbirth, microcephaly, hydrocephalus, mental retar-
dation, abortion, cerebral calcification in the developing
fetus, and fetal death (10). Moreover, in immunosup-
pressed patients, such as AIDS patients, patients undergo-
ing therapies for malignancies, recipients of solid-organ
transplants, and people on hemodialysis, it causes irre-
versible complications including encephalitis, pneumo-
nia, and disseminated systematic disease (11, 12).
Another risk group consists of patients with aplastic
anemia, sickle cell anemia, thalassemia, and lymphopro-
liferative disorders who receive blood transfusion regu-
larly or frequently for survival. The transfusion of infected
blood in these patients due to their immunodeficiency dis-
orders would cause serious disease (13, 14). Toxoplasma
gondii is one of the intracellular microorganisms that can
stay alive for up to 50 days in the citrated blood and the
buffy coat at 5°C (15). Therefore, this parasite is potent
for transmission via blood and blood components such
as leukocytes. However, many countries do not perform
rigorous screening on blood as a routine procedure be-
fore blood transfusion. Therefore, scientific surveys have
been carried out to investigate the relationship between
T. gondii and blood safety in blood donors and blood bags
by different techniques such as serological and molecu-
lar methods. Many investigations have indicated that the
seroprevalence of toxoplasmosis varies widely from 0.96%
to 73.26% in healthy volunteer blood donors in different
countries. In Iran, the seroprevalence of toxoplasmosis in
healthy volunteer blood donors is reported from 16.8% to
56.3% in different geographic areas (6, 8, 16-19).
2. Objectives
The aim of this cross-sectional study was to evaluate
the prevalence of T. gondii infection using serological and
molecular methods and determine the associated risk fac-
tors among healthy blood donors in Chaharmahal and
Bakhtiari province, Southwest Iran.
3. Methods
3.1. Study Design
This cross-sectional study was carried out at the three
biggest Blood Transfusion Organization centers of Cha-
harmahal and Bakhtiari province, Iran. The province is lo-
cated between 31° 09’ North latitude and 32° 48’ East longi-
tude in the mountainous areas of Southwestern Iran, cov-
ering an area of 16,332 square kilometers, with a popula-
tion of about 895,263. It is characterized by various cli-
mates from cold, snowy, and rainy weather especially in fall
and winter to hot weather in summer. Animal husbandry,
farming, and gardening are common in this province and
the diet of most people contains meat, milk, and local veg-
etables.
3.2. Sample Collection and Participants
In this study, according to statistical calculations, the
sample size was determined to be 385 cases based on the
prevalence of 50% as reported in some studies from Iran
(17, 20, 21), the confidence level of 95%, and the error
of 0.05. Blood samples were collected from apparently
healthy blood donors from seven counties of the province,
Shahrekord, Lordegan, Boroujen, Farsan, Kiar, Ardal, and
Kohrang. The donors referred to the three biggest Blood
Transfusion Organization centers in the province during
the period from January to June 2017.
Before collecting the blood samples, a questionnaire
was administered to inquire about socio-demographic in-
formation of the donors including age, sex, job, residence,
education level, and blood group. Moreover, other possi-
ble risk factors were recorded such as contact with animals
(cats), raw/half-cocked meat consumption, raw milk/egg
consumption, raw vegetable consumption, and history of
blood transfusion. Then, 5 mL of venous blood was asep-
tically taken from each apparently healthy donor and di-
vided into two parts. One part was transferred into plas-
tic tubes containing K2EDTA as an anticoagulant for isolat-
ing buffy coat for molecular assay and the other part was
poured into a disposable tube free of anti-coagulants to iso-
late sera for serological assay.
The specimen was left for 15 - 30 minutes or put in the
water bath at 37°C. Then, it was centrifuged at 3000 rpm for
5 minutes to separate clear serum. Moreover, all donated
blood samples were assayed to determine blood groups
and Rh factors. All the blood samples were routinely tested
in terms of antibodies against human immunodeficiency
virus (HIV), hepatitis C virus (HCV), hepatitis B virus surface
antigen (HBsAg), and Treponema pallidum infection. None
of the blood donors was seropositive for the infection with
these microorganisms. After being collected, the samples
were transported to the Parasitology Laboratory, Depart-
ment of Parasitology and Mycology, Shahrekord University
of Medical Sciences, and kept at -20°C until the day of the
experiment.
3.3. Serological Assay
IgM and IgG antibodies against T. gondii were tested
in all serum samples using the commercially available
enzyme-linked immunosorbent assay (ELISA) kit (Pishtaz
Teb Co. Tehran, Iran) according to the instructions of the
manufacturer. The IgG antibody titer was considered posi-
tive if the values were≥ 10 mL/IU and negative if they were
< 10 mL/IU. In addition, anti-T. gondii IgM antibody levels of
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≥ 1.1 mL/IU and < 0.9 mL/IU were defined as positive and
negative, respectively.
3.4. Molecular Diagnosis
Loop-mediated isothermal amplification (LAMP) is one
of the new easy-to-perform molecular methods for detec-
tion of DNA of different microorganisms by nucleic acid
amplification with extremely high sensitivity and speci-
ficity to discriminate single nucleotides. The technique
was performed by a DNA polymerase with strand displace-
ment activity, a set of two specially designed inner primers
(FIP and BIP), and two outer primers (F3 and B3) that ampli-
fied DNA with high specificity, efficiency, and rapidity un-
der isothermal conditions (22). Therefore, we used LAMP
to detect DNA of T. gondii in blood samples of donors.
First, DNA was extracted from buffy coat of all samples
by a commercial DNA extraction kit DNG-Plus™ (DN8118C,
Cinnaclon Co., Iran) according to the manufacturer’s in-
structions. Genomic DNA was extracted from the T. gondii
tachyzoites of RH strain provided by the Toxoplasmosis Re-
search Center, Mazandaran University of Medical Sciences
(Sari, Iran), as a positive control. Then, the concentration
and quality of DNA were determined using an ND-1000
spectrophotometer (Nanodrop Technologies, USA). Each T.
gondii one 80-Mbp genome was equal to about 80 fg DNA.
In the LAMP assay, the designed primers were used for 529
bp repeated elements of T. gondii (23).
The LAMP assay was carried out in a reaction mixture
(25µL) containing 1µL of template DNA, 40 pmol of each of
FIP and BIP primers, 20 pmol of each of LF and LB primers,
5 pmol of each of F3 and B3 primers, 8 U of Bst DNA poly-
merase (New England Biolabs, USA), 1.4 mM of deoxynu-
cleoside triphosphates (dNTP), and 2× reaction buffer (1.6
M betaine (Sigma-Aldrich), 40 mM of Tris-HCl (pH 8.8), 20
mM of KCl, 20 mM of (NH4)2SO4, 16 mM of MgSO4, and
0.2% Tween 20). In order to determine the optimal time
and temperature conditions for the LAMP assay, the reac-
tions including positive control (T. gondii RH-strain DNA)
and negative control (double distilled water) were carried
out at 60 to 67°C for 30, 45, 60, and 75 minutes (24). Loop-
mediated isothermal amplification products were visual-
ized by 1.5% agarose gel electrophoresis stained with ethid-
ium bromide solution (1 µg/mL). In addition, LAMP ampli-
cons in the reaction tube were evaluated by visual inspec-
tion that was performed by adding 1 µL of 1:10 dilution of
SYBR green I (invitrogen lot: 49743A, USA). After the reac-
tion, fluorescent signals of the solutions were observed un-
der UV light.
3.5. Statistical Analyses
SPSS 20.0 software (SPSS Inc., Chicago, IL, USA) was used
for all descriptive and inferential statistics. The chi-square
test was applied to access the univariate association be-
tween independent variables and outcome. The associa-
tion between T. gondii seropositivity and the potential risk
factors were evaluated using multifactorial logistic regres-
sion model. In this survey, P < 0.05 was considered statisti-
cally significant.
4. Results
4.1. Participants
Blood samples in this survey belonged to 385 healthy
blood donors, including 365 (94.8%) men and 20 (5.2%)
women. The participants’ mean age± SD was 37.2± 9.81
years, with the youngest and oldest being 20 and 71 years,
respectively. Most participants were aged 26 - 35 years, liv-
ing in urban areas, and had a college education or above.
4.2. Seroprevalence of Anti-Toxoplasma gondii Antibodies
The serological tests indicated that anti-T. gondii anti-
bodies were detected in 154 (40%) serum samples of the 385
blood donors. Moreover, 146 (37.9%) cases were seroposi-
tive for IgG antibody, six (1.56%) for both IgM and IgG, and
four (1.03%) for IgM antibody alone. Therefore, the preva-
lence rate of IgG and IgM antibodies against T. gondii was
37.9% and 1.03%, respectively. Regarding geographical loca-
tion, as shown by the ELISA test, the seroprevalence rates
of anti-T. gondii IgG antibody were 71.2%, 5.5%, 5.5%, 4.8%, 4.1%,
4.1%, 2.3%, 2.3%, and 0.7% in Shahrekord, Saman, Kiar, Farsan,
Ardal, Ben, Lordegan, and Koohrang, respectively. In terms
of gender, the seroprevalence rate of anti-T. gondii IgG an-
tibody was significantly higher in female donors than in
male donors. The rates of anti-T. gondii IgG antibody in fe-
males and males were 65% and 36.4%, respectively.
4.3. Risk Factors of Anti-Toxoplasma gondii Antibodies
Several risk factors, including gender, age, residence
place, education level, blood type, diet, and contact with
cats, which were possibly associated with toxoplasmosis,
were evaluated by statistical methods including descrip-
tive and inferential statistics. The results demonstrated
that four variables, including gender, age, contact with
cats, and consumption of undercooked meat, were signif-
icantly related to T. gondii seropositivity in blood donors.
However, other risk factors and demographic features of
blood donors did not show any statistical association with
the acquisition of toxoplasmosis (Tables 1 and 2).
4.4. Detection of Toxoplasma gondii DNA by LAMP
All blood samples were tested using the LAMP assay for
the presence of T. gondii DNA. The DNA was found in six
(1.56%) samples, four of which had IgG and IgM anti-T. gondii
antibodies and two had only IgG antibody in the serologi-
cal assay (Figures 1 and 2).
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Table 1. The Prevalence of Toxoplasmosis Based on Demographic Characteristics Detected by Different Methods Among Healthy Blood Donors in Chaharmahal and Bakhtiari
Province, Southwest Irana
Variable No. (%) Seropositive Antibodies LAMP Positivity
Positive (%) Positive IgM (%)
Gender
Male 365 (94.8) 133 (36.4) 3 (0.82) 5 (1.37)
Female 20 (5.2) 13 (65) 1 (5) 1 (5)
Age group, y
< 25 42 (10.9) 10 (23.8)
26 - 35 146 (37.9) 43 (29.6) 3 (2.1) 3 (2.1)
36 - 45 118 (30.6) 55 (46.6) 1 (0.85) 2 (1.7)
> 45 79 (20.5) 38 (48.1) 1 (1.27)
Residence place
Urban areas 329 (85.5) 127 (38.6) 4 (1.2) 6 (1.8)
Rural areas 56 (14.5) 19 (33.9)
Education
Illiterate 4 (1) 3 (75)
Primary school 35 (9.1) 14 (40) 1 (2.86)
Middle school 66 (17.1) 29 (43.9) 1 (1.5) 2 (3)
High school 147 (38.2) 51 (34.7) 1 (0.68) 1 (0.7)
Graduate 133 (34.5) 49 (36.8) 2 (1.5) 2 (1.5)
Blood type
A+ 115 (29.9) 39 (33.9) 2 (1.74) 3 (2.6)
A- 15 (3.9) 6 (40) 1 (6.7)
B+ 66 (17.1) 35 (53)
B- 6 (1.6) 3 (50) 1 (50) 1 (16.7)
AB+ 24 (6.2) 10 (41.7)
AB- 7 (1.8) 3 (42.9)
O+ 53 (13.8) 13 (24.5)
O- 99 (25.7) 37 (37.4) 1 (1.01) 1 (1.01)
Contact with cats
Yes 49 (12.7) 28 (57.1) 1 (2)
No 336 (87.3) 118 (35.1) 4 (1.2) 5 (1.5)
Raw/half-cooked meat consumption
Yes 25 (6.5) 11 (44) 1 (4)
No 360 (93.5) 135 (37.5) 4 (1.1) 5 (1.4)
Raw milk/egg consumption
Yes 223 (57.9) 85 (38.1) 1 (0.45) 2 (0.9)
No 162 (42.1) 61 (37.7) 3 (1.9) 4 (2.5)
Unwashed vegetables consumption
Yes 14 (3.6) 4 (28) 1 (7.1) 3 (21.4)
No 371 (94.4) 90 (24.3) 3 (0.8) 3 (0.8)
Blood transfusion
Yes 0 (0)
No 385 (100) 146 (37.9) 4 (1.03) 6 (1.6)
aValues are expressed as No. (%).
5. Discussion
Organ transplantation and blood transfusion can be of
the potential transmission routes of T. gondii. These routes
of transmission are less common; however, if donors
are infected, it will cause acute toxoplasmosis because
the recipients are usually immunocompromised patients,
with significant clinical consequences such as encephali-
tis, brain abscess, myocarditis, and chorioretinitis (10). De-
spite the serious complications of this parasitic disease, es-
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Table 2. Correlation Between Demographic Characteristics and IgG Anti-Toxoplasma gondii Antibodies Among Healthy Blood Donors in Chaharmahal and Bakhtiari Province,
Southwest Irana
Variable No. (%) Seropositive Antibodies IgG (%) P Value OR 95% CI
Gender
Male 365 (94.8) 133 (36.4) 0.015b 3.240 1.261 - 8.320
Female 20 (5.2) 13 (65) - 1
Age group, y
< 25 42 (10.9) 10 (23.8) 0.011 2.966 1.285 - 6.843
26 - 35 146 (37.9) 43 (29.6) 0.006b 2.220 1.259 - 3.914
36 - 45 118 (30.6) 55 (46.6) 0.837 1.062 0.60 - 1.878
> 45 79 (20.5) 38 (48.1) - 1
Residence place
Urban areas 329 (85.5) 127 (38.6) 0.506 0.817 0.450 - 1.482
Rural areas 56 (14.5) 19 (33.9) - 1
Education
Illiterate 4 (1) 3 (75) 0.161 .194 0.020 - 1.921
Primary school school 35 (9.1) 14 (40) 0.731 0.875 0.408 - 1.876
Middle school school school 66 (17.1) 29 (43.9) 0.335 0.744 0.408 - 1.357
High school 147 (38.2) 51 (34.7) 0.708 1.098 0.673 - 1.791
Graduate 133 (34.5) 49 (36.8) - 1
Blood type
A+ 115 (29.9) 39 (33.9) 0.598 1.163 0.664 - 2.038
A- 15 (3.9) 6 (40) 0.845 0.895 0.295 - 2.717
B+ 66 (17.1) 35 (53) 0.048 0.529 0.281 - 0.994
B- 6 (1.6) 3 (50) 0.540 0.597 0.114 - 3.111
AB+ 24 (6.2) 10 (41.7) 0.698 0.835 0.337 - 2.071
AB- 7 (1.8) 3 (42.9) 0.773 0.796 0.169 - 3.754
O+ 53 (13.8) 13 (24.5) 0.111 1.836 0.870 - 3.874
O- 99 (25.7) 37 (37.4) - 1
Contact with cats
Yes 49 (12.7) 28 (57.1) 0.004b 0.406 0.221 - 0.746
No 336 (87.3) 118 (35.1) - 1
Raw/half-cooked meat consumption
Yes 25 (6.5) 11 (44) 0.004b 0.406 0.221 - 0.746
No 360 (93.5) 135 (37.5) - 1
Raw milk/egg consumption
Yes 223 (57.9) 85 (38.1) 0.926 0.981 0.646 - 1.488
No 162 (42.1) 61 (37.7) - 1
Unwashed vegetables consumption
Yes 14 (3.6) 4 (28) 0.826 1.049 0.686 - 1.603
No 371 (94.4) 90 (24.3) - 1
Blood transfusion
Yes 0 (0)
No 385 (100) 146 (37.9)
Abbreviation: OR: odds ratio.
aValues are expressed as No. (%).
bP < 0.05, statistically significant difference.
pecially in immunocompromised patients, available treat-
ments are not fully effective; moreover, safe and efficacious
vaccines are not available; thus, the prevention of para-
site transmission is one of the effective strategies for re-
ducing toxoplasmosis (25). Detecting the source of infec-
tion such as infected blood and organs for recipient can-
didates, especially patients undergoing multiple transfu-
sions or those requiring blood transfusion for transplan-
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Figure 1. Amplification of Toxoplasma gondii DNA in blood samples using the LAMP
assay; positive reactions turned green after the addition of SYBR green I while the
negative reactions remained uncolored; C+, positive control; C-, negative control;
tubes 1–6, randomly selected samples from patients.
Figure 2. Amplification of T. gondii DNA in blood samples using the LAMP assay
on 1.5% agarose gel staining with ethidium bromide. L, 100 bp molecular weight
marker; C+, positive control; C-, negative control; lanes 1–6, randomly selected sam-
ples from patients.
tation management, can be crucial to control and prevent
toxoplasmosis (16). Currently, T. gondii screening in blood
and blood products of blood donors is not routinely con-
sidered in worldwide therefore certainly do not assay the
relationship between T. gondii and blood safety in blood
transfusion centers.
In this study, 385 blood samples were collected from
healthy blood donors from Chaharmahal and Bakhtiari
province, Iran, and were evaluated by serological and
molecular methods for T. gondii infection. The results in-
dicated that 154 (40%) samples were seropositive for anti-T.
gondii antibodies while 37.9% and 1.56% were positive for
IgG and IgM anti-T. gondii antibodies, respectively. These
findings showed a considerable prevalence rate of toxo-
plasmosis in this population. Although seropositivity of
IgG (latent infection) was high, the rate of anti-T. gondii IgM
antibodies (acute infection) was low.
Previous investigations conducted in Iran showed that
the seroprevalence of T. gondii in volunteer blood donors
was reported to be 34.4% (95% CI: 24.9% - 43.9%), rang-
ing from 18.3% in Gonabad city (26) to 56.4% in Hamedan
province (20). However, different rates were reported for
various regions by serological methods for IgG and IgM an-
tibodies respectively as 25% and 0% in Zahedan (Southeast
Iran) (27), 25% and 3.2% in Mashhad (Northeast Iran) (28),
37.8% and 0% in Urmia (Northwest Iran) (29), 38.66% and
1.03% in Tabriz (Northwest Iran) (21), 16.30% and 0.7% in
Boyer-Ahmad county (Southwest Iran), 34.47% and 0.5% in
Ahvaz (Southwest Iran) (17), and 28.8% and 3.2%in Kerman
(Southeast Iran) (30), which may be related to living con-
ditions, geographical and environmental factors, sanitary
conditions, economic and social situation of blood donors,
sample size, and sensitivity of detection methods.
The overall seroepidemiological studies of T. gondii on
blood donors in different regions of the world indicated
very different prevalence rates for IgG and IgM antibodies
from 0.64% and 0% to 70.29% and 5.81%, respectively (8).
The highest seroprevalence rates were from Brazil (75%) (31)
and Ethiopia (73%) (32) while low seroprevalence rates of
toxoplasmosis in blood donors were observed in Namibia
(0.96%) (33), Thailand (9.6%), Taiwan (9.3%), and Mexico
(7.4%) (17).
In the present study, the obtained results showed that
the seroprevalence of T. gondii was significantly higher in
female than in male donors, which may be due to sam-
pling bias because most blood donors were males. Simi-
larly, Mahmoudvand et al. (30) and Sundar et al. (34) re-
ported that the seroprevalence of T. gondii in female donors
was significantly higher than that in male donors. How-
ever, some studies reported contradictory results (28, 35).
According to a recently published systematic review
of toxoplasmosis in Iranian blood donors, the difference
between men and women was not statistically significant
(36). Regarding age groups, IgG positivity was more fre-
quent in donors aged > 45 years that was similar to other
studies indicating that the rate of seropositivity increased
with age as a consequence of the increased opportunity of
acquiring the infection. The obtained findings disclosed
that blood donors with blood group B+ had more Toxo-
plasma seropositivity than other blood groups; however,
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no correlation was found between T. gondii seropositivity
and blood groups. Shaapan et al. reported that blood
group A (48.7%) had the most frequent Toxoplasma seropos-
itivity among blood donors from Egypt (37). However, Mah-
moudvand et al., (30) Shaddel et al., (38) and Elsheikha et
al. (19) indicated a significant correlation between toxo-
plasmosis and blood groups AB, A, and O, respectively. Due
to the small number of reports of the correlation between
toxoplasmosis and blood groups, this hypothesis needs to
be confirmed in further investigations.
Although cats are the definitive host of this protozoon
and infected cats can infect the environment by defecated
oocysts, conflicting findings have been reported concern-
ing the transmission of T. gondii via contact with cats. How-
ever, our study suggested that contact with cats is a po-
tential risk factor for acquiring toxoplasmosis. Concern-
ing food habits, the study exhibited that the seropreva-
lence rate of toxoplasmosis was higher in blood donors
who consumed raw/half-cooked meat than in other blood
donors. Therefore, ingesting meat containing tissue cysts
seems to be the main route of infection among the other
routes. Moreover, some studies such as Mahmoudvand et
al. study confirmed this finding (30). In this study, no sig-
nificant relationships were found between the consump-
tion of raw vegetables, occupational activities, education
level, residence place, blood transfusion, and raw milk/egg
consumption (as potential risk factors for acquiring toxo-
plasmosis) and seropositivity of T. gondii.
Despite this fact that serological methods such as ELISA
are used in many medical diagnostic laboratories for de-
tecting antibodies against T. gondii, these methods have
false-positive results and cannot differentiate past and
present infections; therefore, the diagnosis of toxoplasmo-
sis remains unsatisfactory with serological methods. This
is while molecular methods can obviate this limitation (39,
40). Many researchers have used molecular methods such
as PCR and real-time PCR for detecting T. gondii in blood
donors. Studies carried out based on the detection of DNA
of T. gondii in blood donors in Iran indicated that 0.9% of
IgM-positive samples in Kerman (30), 6.97% samples in Raf-
sanjan (18), 40% of seropositive samples in Ahvaz (17), and
100% of IgM-positive samples in Razavi Khorasan (41) con-
tained the DNA of the parasite. Nevertheless, by the PCR
method, T. gondii DNA was not detected in the buffy coat
of any of the seropositive cases in Boyer-Ahmad County,
Southwest Iran (42).
Our findings according to the molecular assay demon-
strated that six (1.56%) samples had the DNA of T. gondii. Of
these, four (1.04%) were seropositive for both IgG and IgM
antibodies and two (0.52%) were positive only for IgG an-
tibody. In line with these findings, Fallahi et al. reported
that LAMP is a useful tool for the diagnosis of toxoplas-
mosis in children with leukemia with high sensitivity and
specificity (24). Loop-mediated isothermal amplification
is an attractive DNA amplification method compared to
other molecular methods such as PCR because it requires
a minimal DNA sample such as a single tachyzoite or 10
copies of recombinant plasmid whereas the PCR method
in toxoplasmosis diagnosis needs much more DNA sample
(24, 39). Furthermore, the LAMP assay was very simple, as
the reaction would be carried out in a single tube under
one isothermal condition and at one-hour reaction time.
Therefore, the LAMP method has the advantages of speci-
ficity, rapidity, sensitivity, and easiness for the clinical di-
agnosis of T. gondii (43).
5.1. Conclusions
In conclusion, the results demonstrated that the preva-
lence of T. gondii infection is high among apparently
healthy blood donors in Southwest Iran. Thus, there
is the possibility of transmission of infection by blood
transfusion while screening tests are not used to detect
Toxoplasma infection in Blood Transfusion Organizations.
Furthermore, serological methods have potential weak-
nesses such as time-intensiveness and false-positive re-
sults. Therefore, it is strongly suggested that appropriate
and sensitivity programs be designed for screening of tox-
oplasmosis by the LAMP method to detect T. gondii DNA in
blood donors and prevent the transmission of T. gondii to
at-risk people, especially multi-transfused patients.
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